Anticoagulant Utilization Pattern

CompletedOBSERVATIONAL
Enrollment

333,664

Participants

Timeline

Start Date

April 17, 2013

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2017

Conditions
Atrial Fibrillation
Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01847560 - Anticoagulant Utilization Pattern | Biotech Hunter | Biotech Hunter